Get the Stockscreener App
0.4901
1.92%
-0.0096
After Hours:
.49
-0.000100
-0.02%
Rani Therapeutics Holdings Inc stock is traded at $0.4901, with a volume of 328.92K.
It is down -1.92% in the last 24 hours and down -1.98% over the past month.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
See More
Previous Close:
$0.4997
Open:
$0.499
24h Volume:
328.92K
Relative Volume:
0.19
Market Cap:
$23.08M
Revenue:
$1.20M
Net Income/Loss:
$-52.41M
P/E Ratio:
-0.5386
EPS:
-0.91
Net Cash Flow:
$-31.25M
1W Performance:
-3.71%
1M Performance:
-1.98%
6M Performance:
-53.76%
1Y Performance:
-77.62%
1-Day Range:
$0.4851
$0.499
1-Week Range:
$0.4803
$0.5279
52-Week Range:
$0.387
$3.75
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
Name
Rani Therapeutics Holdings Inc
Sector
Industry
Phone
(408) 457-3700
Address
2051 RINGWOOD AVENUE, SAN JOSE
Compare RANI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
0.4901 | 23.93M | 1.20M | -52.41M | -31.25M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-02-24 | Initiated | Oppenheimer | Outperform |
| Jun-14-24 | Initiated | Maxim Group | Buy |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Apr-17-23 | Resumed | BTIG Research | Buy |
| Oct-11-22 | Initiated | UBS | Buy |
| Jul-27-22 | Initiated | H.C. Wainwright | Buy |
| Jun-13-22 | Initiated | Wedbush | Outperform |
View All
Rani Therapeutics Holdings Inc Stock (RANI) Latest News
What drives Rani Therapeutics Holdings Inc stock priceMarket Rumors and News & Exceptional Profit Growth Tips - earlytimes.in
What analysts say about Rani Therapeutics Holdings Inc stockUtilities Sector Analysis & Access Powerful Market Insights - earlytimes.in
Is Rani Therapeutics Holdings Inc. stock affected by interest rate hikesJuly 2025 Analyst Calls & High Yield Equity Trading Tips - newser.com
Why Rani Therapeutics Holdings Inc. stock could outperform in 2025July 2025 Recap & Weekly Market Pulse Alerts - newser.com
Price momentum metrics for Rani Therapeutics Holdings Inc. explainedJuly 2025 Price Swings & Free Weekly Chart Analysis and Trade Guides - newser.com
Price action breakdown for Rani Therapeutics Holdings Inc.July 2025 Retail & Safe Swing Trade Setups - newser.com
Building trade automation scripts for Rani Therapeutics Holdings Inc.Earnings Summary Report & Daily Momentum Trading Reports - newser.com
Top chart patterns to watch in Rani Therapeutics Holdings Inc.2025 Geopolitical Influence & High Accuracy Investment Signals - newser.com
Momentum Shift: Can Rani Therapeutics Holdings Inc beat the S P 500Weekly Investment Recap & AI Powered Market Entry Strategies - khodrobank.com
Published on: 2025-09-21 03:12:07 - khodrobank.com
Rani Therapeutics Holdings Inc. stock momentum explainedInsider Buying & Reliable Momentum Entry Alerts - newser.com
Rani Therapeutics Holdings Inc. recovery potential after sell offAnalyst Upgrade & Verified Entry Point Signals - newser.com
Real time social sentiment graph for Rani Therapeutics Holdings Inc.Market Rally & Community Verified Watchlist Alerts - newser.com
Quarterly Trades: Will Rani Therapeutics Holdings Inc. benefit from geopolitical trendsDip Buying & Smart Money Movement Tracker - khodrobank.com
Signal strength of Rani Therapeutics Holdings Inc. stock in tech scannersQuarterly Profit Report & Free Technical Pattern Based Buy Signals - newser.com
Detecting price anomalies in Rani Therapeutics Holdings Inc. with AI2025 Trading Recap & AI Forecast for Swing Trade Picks - newser.com
Will Rani Therapeutics Holdings Inc. stock go up soon2025 Support & Resistance & Weekly Momentum Stock Picks - newser.com
Can technical indicators confirm Rani Therapeutics Holdings Inc.’s reversal2025 Trade Ideas & High Conviction Investment Ideas - newser.com
Risk Hedge: Is Xilio Therapeutics Inc attractive for institutional investorsTreasury Yields & Detailed Earnings Play Alerts - khodrobank.com
Published on: 2025-09-19 01:29:41 - خودرو بانک
Aug Reactions: Is Soleno Therapeutics Inc. in a bullish channel2025 EndofYear Setup & Free High Accuracy Swing Entry Alerts - خودرو بانک
Short Covering: Whats next for Rani Therapeutics Holdings Inc stock2025 Geopolitical Influence & Safe Entry Point Identification - خودرو بانک
What machine learning models say about Rani Therapeutics Holdings Inc.Take Profit & Consistent Growth Equity Picks - newser.com
Smart tools for monitoring Rani Therapeutics Holdings Inc.’s price actionJuly 2025 Intraday Action & Expert Verified Movement Alerts - newser.com
Custom strategy builders for tracking Rani Therapeutics Holdings Inc.July 2025 Intraday Action & High Yield Stock Recommendations - newser.com
Aug Spikes: What analysts say about Rani Therapeutics Holdings Inc. stockWeekly Trade Report & Intraday High Probability Alerts - khodrobank.com
Rani Therapeutics Holdings Inc Stock (RANI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Rani Therapeutics Holdings Inc Stock (RANI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Imran Talat | Chief Executive Officer |
Dec 09 '24 |
Buy |
1.94 |
10,296 |
19,974 |
494,751 |
| South Cone Investments Limited | 10% Owner |
Oct 15 '24 |
Sale |
2.65 |
3,829,360 |
10,141,674 |
8,302,194 |
2.05%
4.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):